Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection-Reference-Cited by-同舟云学术

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

Published:2015-07-07 Issue:1 Volume:163 Page:1-13
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Zeuzem Stefan¹,Ghalib Reem¹,Reddy K. Rajender¹,Pockros Paul J.¹,Ari Ziv Ben¹,Zhao Yue¹,Brown Deborah D.¹,Wan Shuyan¹,DiNubile Mark J.¹,Nguyen Bach-Yen¹,Robertson Michael N.¹,Wahl Janice¹,Barr Eliav¹,Butterton Joan R.¹

Affiliation:

1. From Goethe University Hospital, Frankfurt, Germany; Texas Clinical Research Institute, Dallas, Texas; University of Pennsylvania, Philadelphia, Pennsylvania; Scripps Translational Science Institute, La Jolla, California; Sheba Medical Center, Ramat Gan, Israel; and Merck & Co., Kenilworth, New Jersey.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 486 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

2. Progress in diagnosis and treatment of hepatitis C;World Chinese Journal of Digestology;2024-07-28

3. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review;Microorganisms;2024-05-21

4. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

5. A Systematic Review on the Evolution of Natural Mutation-dependent Antiviral Drug Resistance in Hepatitis C Virus (HCV) Genotypes Prevalent in Saudi Arabia: A Genomic and Therapeutic Perspective;The Natural Products Journal;2024-04-03